News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
80,767 Results
Type
Article (5231)
Company Profile (14)
Press Release (75521)
Multimedia
Podcasts (10)
Webinars (1)
Section
Business (23065)
Career Advice (127)
Deals (3096)
Drug Delivery (20)
Drug Development (11064)
Employer Resources (11)
FDA (1751)
Job Trends (2131)
News (38263)
Policy (2868)
Tag
2027 Genetown Standard (1)
Academia (604)
Accelerated approval (3)
Adcomms (2)
Allergies (20)
Alliances (6190)
ALS (28)
Alzheimer's disease (351)
Antibody-drug conjugate (ADC) (47)
Approvals (1874)
Artificial intelligence (132)
Autoimmune disease (29)
Automation (6)
Bankruptcy (18)
Best Places to Work (1957)
Biosimilars (20)
Biotechnology (8)
Bladder cancer (19)
Brain cancer (14)
Breast cancer (97)
Cancer (773)
Cardiovascular disease (74)
Career advice (116)
Career pathing (7)
CAR-T (29)
CDC (3)
Celiac Disease (1)
Cell therapy (116)
Cervical cancer (7)
Clinical research (9599)
Collaboration (358)
Compensation (38)
Complete response letters (8)
COVID-19 (335)
CRISPR (28)
C-suite (254)
Cystic fibrosis (154)
Data (1223)
Denatured (8)
Depression (16)
Diabetes (67)
Diagnostics (821)
Digital health (6)
Diversity (3)
Diversity, equity & inclusion (4)
Drug discovery (66)
Drug pricing (17)
Duchenne muscular dystrophy (43)
Earnings (7112)
Editorial (6)
Employer branding (2)
Employer resources (10)
Events (11118)
Executive appointments (241)
FDA (2287)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (420)
Gene editing (48)
Generative AI (14)
Gene therapy (95)
GLP-1 (180)
Government (520)
Guidances (56)
Healthcare (2779)
HIV (22)
Huntington's disease (6)
IgA nephropathy (36)
Immunology and inflammation (33)
Immuno-oncology (9)
Indications (23)
Infectious disease (382)
Inflammatory bowel disease (67)
Inflation Reduction Act (2)
Influenza (21)
Intellectual property (58)
Interviews (13)
IPO (1537)
IRA (2)
Job creations (236)
Job search strategy (98)
JPM (7)
Labor market (7)
Layoffs (50)
Leadership (4)
Legal (452)
Liver cancer (17)
Longevity (5)
Lung cancer (97)
Lymphoma (59)
Machine learning (10)
Management (3)
Manufacturing (116)
MASH (129)
Medical device (1276)
Medtech (1284)
Mergers & acquisitions (1715)
Metabolic disorders (252)
Multiple sclerosis (16)
NASH (19)
Neurodegenerative disease (63)
Neuropsychiatric disorders (9)
Neuroscience (615)
NextGen: Class of 2026 (975)
Non-profit (2454)
Now hiring (7)
Obesity (64)
Opinion (46)
Ovarian cancer (30)
Pain (20)
Pancreatic cancer (37)
Parkinson's disease (107)
Partnered (5)
Patents (93)
Patient recruitment (83)
Peanut (11)
People (9497)
Pharmaceutical (5)
Pharmacy benefit managers (4)
Phase 1 (2848)
Phase 2 (4592)
Phase 3 (3132)
Pipeline (1069)
Policy (21)
Postmarket research (282)
Preclinical (1314)
Press Release (15)
Prostate cancer (41)
Psychedelics (3)
Radiopharmaceuticals (28)
Rare diseases (298)
Real estate (501)
Recruiting (2)
Regulatory (2586)
Reports (3)
Research institute (597)
Resumes & cover letters (15)
Rett syndrome (6)
RNA editing (3)
RSV (15)
Schizophrenia (30)
Series A (66)
Series B (46)
Sickle cell disease (23)
Special edition (3)
Spinal muscular atrophy (84)
Sponsored (6)
Startups (589)
Supply chain (12)
Tariffs (2)
The Weekly (2)
Vaccines (106)
Venture capital (16)
Weight loss (29)
Women's health (17)
Worklife (2)
Date
Last 7 days (116)
Last 30 days (373)
Last 365 days (4904)
2026 (704)
2025 (4766)
2024 (4911)
2023 (5669)
2022 (6766)
2021 (7817)
2020 (7535)
2019 (7003)
2018 (5198)
2017 (3994)
2016 (3933)
2015 (4100)
2014 (2888)
2013 (2130)
2012 (2115)
2011 (2182)
2010 (1642)
Location
Africa (105)
Alabama (6)
Alaska (2)
Arizona (29)
Arkansas (1)
Asia (4232)
Australia (791)
California (1736)
Canada (428)
China (147)
Colorado (53)
Connecticut (153)
Delaware (54)
Europe (10827)
Florida (220)
Georgia (91)
Idaho (9)
Illinois (124)
India (9)
Indiana (51)
Iowa (8)
Japan (76)
Kansas (14)
Kentucky (8)
Louisiana (3)
Maine (6)
Maryland (206)
Massachusetts (1278)
Michigan (40)
Minnesota (42)
Mississippi (2)
Missouri (36)
Montana (10)
Nebraska (6)
Nevada (21)
New Hampshire (13)
New Jersey (378)
New Mexico (5)
New York (480)
North Carolina (226)
North Dakota (2)
Northern California (850)
Ohio (54)
Oklahoma (5)
Oregon (5)
Pennsylvania (354)
Rhode Island (11)
South America (107)
South Carolina (5)
South Dakota (1)
Southern California (679)
Tennessee (19)
Texas (266)
United States (5985)
Utah (50)
Virginia (29)
Washington D.C. (12)
Washington State (111)
West Virginia (1)
Wisconsin (15)
80,767 Results for "cystic fibrosis foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cystic fibrosis
Arcturus Plunges on ‘Mixed’ Cystic Fibrosis Data for Inhaled mRNA Drug
Despite showing no meaningful benefit on lung function, Arcturus’ mRNA therapy ARCT-032 reduced mucus volume in patients with cystic fibrosis—an outcome William Blair found “potentially promising.”
October 23, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC blocker for treatment of Cystic Fibrosis, in The Journal of Cystic Fibrosis
December 10, 2025
·
3 min read
Press Releases
Polarean Highlights New CHEST Journal Study Demonstrating Xenon MRI Predicts Cystic Fibrosis Exacerbations
January 12, 2026
·
6 min read
Press Releases
4DMT Advances 4D-710 to Phase 2 with Additional Funding and Support from the Cystic Fibrosis Foundation
October 14, 2025
·
9 min read
Press Releases
Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK® at the North American Cystic Fibrosis Conference
October 24, 2025
·
15 min read
Press Releases
Clarametyx Biosciences Announces Positive Topline Data From Phase 2a Study Evaluating CMTX-101 in Cystic Fibrosis
January 9, 2026
·
4 min read
Press Releases
BiomX Provides Update on BX004 Phase 2b Trial in Cystic Fibrosis
November 26, 2025
·
6 min read
Press Releases
4DMT Announces Positive Interim Clinical Data from 4D-710 AEROW Phase 1 Clinical Trial in Cystic Fibrosis Lung Disease
December 17, 2025
·
9 min read
Press Releases
Krystal Biotech to Announce Interim Clinical Update from Highest Dose Cohort of Phase 1 CORAL-1 Study Evaluating KB407 in Patients with Cystic Fibrosis
January 8, 2026
·
1 min read
Press Releases
ReCode Therapeutics Initiates Enrollment of Phase 2 Clinical Trial of RCT2100 in Combination with Ivacaftor for the Treatment of Cystic Fibrosis
November 18, 2025
·
3 min read
1 of 8,077
Next
